[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335281-105":59,"doc-detail-335281-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tenascin-c-in-the-early-lung-cancer-tumor-microenvironment-promotes-progression-through-integrin-v1-and-fak","Tenascin-C in the Early Lung Cancer Tumor Microenvironment Promotes Progression Through Integrin αvβ1 and FAK","","Pre-cancerous lung lesions are initiated by activating RAS-pathway mutations but often fail to progress to lung adenocarcinoma (LUAD) without further oncogenic signals. The study shows that the extracellular matrix protein Tenascin-C (TNC) increases and drives the earliest LUAD development stages in oncogenic KRAS-driven mouse models and in human LUAD. TNC begins in fibroblasts and later extends to tumor cells during invasion. TNC loss reduces early tumor burden, high-grade pathology, proliferation, invasion, and FAK activity; it also enhances LUAD cell proliferation and migration via αv-containing integrins and FAK activation. Lung injury sustains TNC accumulation, and patient stage I/II biospecimens link TNC with FAK activation and recurrence after resection.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tenascin-c-in-the-early-lung-cancer-tumor-microenvironment-promotes-progression-through-integrin-v1-and-fak/335281/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tenascin-c-in-the-early-lung-cancer-tumor-microenvironment-promotes-progression-through-integrin-v1-and-fak/335281.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does Tenascin-C relate to early LUAD development?","Question",{"text":112,"@type":113},"Tenascin-C expression increases in KRAS-driven LUAD models and human LUAD, promoting the earliest stages of LUAD development. Its expression shifts from fibroblasts to tumor cells as invasion begins.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What happens when Tenascin-C is genetically deleted in mouse models?",{"text":117,"@type":113},"Genetic deletion of TNC reduces early tumor burden and high-grade pathology. It also diminishes tumor cell proliferation, invasion, and focal adhesion kinase (FAK) activity.",{"name":119,"@type":110,"acceptedAnswer":120},"What signaling pathway links Tenascin-C to tumor cell progression?",{"text":121,"@type":113},"TNC stimulates LUAD tumor cell proliferation and migration by engaging αv-containing integrins and activating FAK. Lung injury further induces sustained TNC accumulation, suggesting injury-driven signaling for early invasive transition.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335281,1790194548,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","bioRxiv preprint doi: [https://doi.org/10.1101/2024.09.17.613509](https://doi.org/10.1101/2024.09.17.613509); this version posted September 21, 2024. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-NC-ND 4.0 International license.  \nTitle: Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin αvβ1 and FAK  \nShiela C. Samson 1,2* , Anthony Rojas 1,2* , Rebecca G. Zitnay2,3* , Keith R. Carney1,2 , Wakeiyo Hettinga2,3 , Mary C. Schaelling 1,2 , Delphine Sicard4 , Wei Zhang2,5 , Melissa Gilbert-Ross6 , Grace  \nK. Dy7 , Michael J. Cavnar8 , Muhammad Furqan9 , Robert F. Browning Jr.10 , Abdul R. Naqash 11 , Bryan P. Schneider12 , Ahmad Tarhini 13 , Daniel J. Tschumperlin4 , Alessandro Venosa 14 , Adam I. Marcus6,15 , Lyska L. Emerson2,5 , Benjamin T. Spike1,2 , Beatrice S. Knudsen2,5 , and Michelle C. Mendoza 1,2,3  \n1 Department of Oncological Sciences, University of Utah, Salt Lake City, UT 84112  \n2 Huntsman Cancer Institute, Salt Lake City, UT 84112  \n3 Department of Biomedical Engineering, University of Utah, Salt Lake City, UT 84112  \n4 Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905  \n5 Department of Pathology, University of Utah, Salt Lake City, UT 84112  \n6 Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322  \n7 Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203  \n8 Department of Surgery, University of Kentucky, Lexington, KY 40508  \n9 Department of Internal Medicine, University of Iowa Health Care, Iowa City, IA 52246  \n10 Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD 20889  \n11 Division of Medical Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104  \n12 Department of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN 46202  \nbioRxiv preprint doi: [https://doi.org/10.1101/2024.09.17.613509](https://doi.org/10.1101/2024.09.17.613509); this version posted September 21, 2024. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-NC-ND 4.0 International license.  \n13 Departments of Cutaneous Oncology and Immunology, H. Lee Moffit Cancer Center & Research Institute, Tampa, FL 33612  \n14 Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112  \n15 Long Island University, College of Veterinary Medicine, Brookville, NY 11548  \n* Equal contribution  \nRunning Title: Tenascin-C in early lung cancer  \nAbbreviations:  \nextracellular matrix (ECM), focal adhesion kinase (FAK), genetically-engineered mouse model (GEMM), lung adenocarcinoma (LUAD), Tenascin-C (TNC)  \nbioRxiv preprint doi: [https://doi.org/10.1101/2024.09.17.613509](https://doi.org/10.1101/2024.09.17.613509); this version posted September 21, 2024. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-NC-ND 4.0 International license.  \nAbstract  \nPre-cancerous lung lesions are commonly initiated by activating mutations in the RAS pathway, but do not transition to lung adenocarcinomas (LUAD) without additional oncogenic signals. Here, we show that expression of the extracellular matrix protein Tenascin-C (TNC) is increased in and promotes the earliest stages of LUAD development in oncogenic KRAS-driven lung cancer mouse models and in human LUAD. TNC is initially expressed by fibroblasts and its expression extends to tumor cells as the tumor becomes invasive. Genetic deletion of TNC in the","cbCaiaT1iKKwiqyA","https://ap.wps.com/l/cbCaiaT1iKKwiqyA","pdf",2997605,62,"English","# Abstract\n# Introduction","[{\"question\":\"How does Tenascin-C relate to early LUAD development?\",\"answer\":\"Tenascin-C expression increases in KRAS-driven LUAD models and human LUAD, promoting the earliest stages of LUAD development. Its expression shifts from fibroblasts to tumor cells as invasion begins.\"},{\"question\":\"What happens when Tenascin-C is genetically deleted in mouse models?\",\"answer\":\"Genetic deletion of TNC reduces early tumor burden and high-grade pathology. It also diminishes tumor cell proliferation, invasion, and focal adhesion kinase (FAK) activity.\"},{\"question\":\"What signaling pathway links Tenascin-C to tumor cell progression?\",\"answer\":\"TNC stimulates LUAD tumor cell proliferation and migration by engaging αv-containing integrins and activating FAK. Lung injury further induces sustained TNC accumulation, suggesting injury-driven signaling for early invasive transition.\"}]","Tenascin-C in the Early Lung Cancer Tumor Microenvironment Promotes Progression Through Integrin αvβ1 and FAK | PDF",1790010386,156]